Education
About Us
Working with TipRanks
Follow Us
Sellas Life Sciences Group (SLS)
NASDAQ:SLS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 1.00M | $ 7.60M | $ 1.90M |
| Gross Profit | $ 0.00 | $ 0.00 | $ 900.00K | $ 7.40M | $ 1.90M |
| Operating Income | $ -31.51M | $ -37.87M | $ -41.95M | $ -25.29M | $ -16.98M |
| EBITDA | $ 632.00K | $ 529.00K | $ -31.49M | $ -18.32M | $ -16.40M |
| Net Income | $ -30.88M | $ -37.34M | $ -41.30M | $ -20.70M | $ -16.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.89M | $ 2.53M | $ 17.13M | $ 21.45M | $ 35.30M |
| Total Assets | $ 19.43M | $ 6.22M | $ 20.94M | $ 26.43M | $ 46.05M |
| Total Debt | $ 1.00M | $ 906.00K | $ 945.00K | $ 808.00K | $ 991.00K |
| Net Debt | $ -12.88M | $ -1.62M | $ -16.18M | $ -20.65M | $ -34.31M |
| Total Liabilities | $ 9.97M | $ 14.20M | $ 16.09M | $ 6.08M | $ 18.09M |
| Stockholders' Equity | $ 9.46M | $ -7.98M | $ 4.85M | $ 20.35M | $ 27.96M |
| Cash Flow | |||||
| Free Cash Flow | $ -35.40M | $ -36.91M | $ -28.31M | $ -26.02M | $ -10.42M |
| Operating Cash Flow | $ -35.40M | $ -31.41M | $ -23.81M | $ -26.02M | $ -10.42M |
| Investing Cash Flow | $ 0.00 | $ -5.50M | $ -4.50M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 46.76M | $ 22.32M | $ 24.08M | $ 12.07M | $ 38.44M |